<scp>FIGO</scp> (International Federation of Gynecology and Obstetrics) Postpregnancy Initiative: Long‐term Maternal Implications of Pregnancy Complications—Follow‐up Considerations

Sheiner, Eyal; Kapur, Anil; Retnakaran, Ravi; Hadar, Eran; Poon, Liona C.; McIntyre, H. David; Divakar, Hema; Staff, Anne Cathrine; Narula, Jagat; Kihara, Anne Beatrice; Hod, Moshe

doi:10.1002/ijgo.12926

Cited by 60 publications

(61 citation statements)

References 225 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This should be completed 6–12 weeks after birth as soon as possible in the context of the resource setting and include aspects relevant to the complication experienced during pregnancy. For more details, see the FIGO Postpregnancy Initiative: Long‐term Maternal Implications of Pregnancy Complications—Follow‐up Considerations 21 .…”

Section: Figo Guidance For Postpartum Obesitymentioning

confidence: 99%

“…Women with obesity during pregnancy require specialist care and recommendations for this are outlined in this article. Maternity costs are higher for women with obesity due to the increased and specialized requirements associated with care and increased use of healthcare services among women with obesity 21 . Such issues highlight the additional importance of nutrition and weight management in the preconception and postpartum periods and to increase awareness about optimal gestational weight gain among clinicians and the general population.…”

Section: Introductionmentioning

confidence: 99%

“…In addition, cultural influences may determine the healthcare professional’s subjective perception of body image and weight and, in the absence of anthropometric measurement and classification, this could result in underestimation and assessment of weight‐related risks. Resources such as the FIGO Nutrition Checklist and guidance may assist obstetricians and gynecologists by increasing professional knowledge and time management when caring for women 21,22,25–27 .…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Management of prepregnancy, pregnancy, and postpartum obesity from the FIGO Pregnancy and Non‐Communicable Diseases Committee: A FIGO (International Federation of Gynecology and Obstetrics) guideline

McAuliffe

Killeen

Jacob

et al. 2020

Intl J Gynecology & Obste

Self Cite

114

View full text Add to dashboard Cite

Obstetricians and gynecologists are well positioned to influence population health through maternity and women's health services. Obesity is common in women of reproductive age and the prevalence is rising in both low-/middle-income and high-income countries 1. Obesity affects requirements for assessment, monitoring, and intervention and can impact maternal and child outcomes. Obstetricians and gynecologists require guidance on the care of women of reproductive age with obesity at all time points related to pregnancy, including how to address modifiable risk factors such as diet and physical activity. Many guidelines have been developed to date, although they vary in scope, methodology, and individual recommendations. FIGO's Committee Guideline for the Management of Prepregnancy, Pregnancy, and Postpartum Obesity (Table 1) reviews good clinical practice recommendations (Table 2-4) from previously published international documents. It serves as a practical resource to support obstetricians and gynecologists in the management of This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

show abstract

Section: Figo Guidance For Postpartum Obesitymentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Management of prepregnancy, pregnancy, and postpartum obesity from the FIGO Pregnancy and Non‐Communicable Diseases Committee: A FIGO (International Federation of Gynecology and Obstetrics) guideline

McAuliffe

Killeen

Jacob

et al. 2020

Intl J Gynecology & Obste

Self Cite

114

View full text Add to dashboard Cite

show abstract

“…It is reported to occur in as many as 5% of pregnancies in the USA and 2% to 6% in Europe [1]. GDM is associated with increased risk of adverse outcomes for both mother and fetus, during and after the pregnancy, including development of cardiovascular disease and metabolic syndrome [1,2].…”

Section: Introductionmentioning

confidence: 99%

Gestational Diabetes Type 2: Variation in High-Density Lipoproteins Composition and Function

Pasternak

Biron‐Shental

Ohana

et al. 2020

IJMS

View full text Add to dashboard Cite

Aims: Class A2 gestational diabetes mellitus (GDMA2) has short- and long-term effects on the mother and child. These may include abnormalities of placentation, damage to endothelial cells and cardiovascular disease. This research investigated the function and composition of high-density lipoproteins (HDL) among women with GDMA2 and their fetuses. Methods: Thirty pregnant women were recruited during admission for delivery. The function and expression of HDL, paraoxonase1 (PON1) and apolipoprotein A1 (APOA1) in the blood samples and the placental tissue were evaluated. The effect of HDL on migration of endothelial cells was measured in vitro. Results: Compared to normal pregnancy (NP), APOA1 in the maternal plasma of women with GDMA2 was decreased. More APOA1 and PON1 were released from HDL of women with GDMA2, compared to NP. Placental APOA1 and PON1 were decreased in GDMA2. For endothelial cells stimulated with TNFα, HDL cell migration was decreased when cells were evaluated with NP-HDL, as compared to GDMA2-HDL. Conclusions: GDMA2 affects the composition and function of HDL in plasma. Changes in HDL commonly seen in GDMA2 were observed in maternal and placental samples, but not in cord samples. These results might indicate a placental role in protecting the fetus by preserving the components and functions of HDL and require further investigation.

show abstract

“…Even though the postpartum maternal cardiovascular legacy of pre‐eclampsia is well recognized, it has always been presumed that this occurs several years remote to the index pregnancy. In the postpartum initiative on the future risk on maternal health from pregnancy co‐morbidities, the International Federation of Gynecology and Obstetrics (FIGO) suggests which strategies would be the most cost‐effective at a population level, given the lack of evidence as to when and how often to follow up these women 11 …”

Section: Introductionmentioning

confidence: 99%

Influence of maternal and perinatal characteristics on risk of postpartum chronic hypertension after pre‐eclampsia

Keepanasseril

Thilaganathan

Velmurugan

et al. 2020

Intl J Gynecology & Obste

View full text Add to dashboard Cite

Objective To assess the prevalence of new‐onset postpartum chronic hypertension (PPCH) after pre‐eclampsia and to determine the factors are associated with it. Methods This study was conducted in a tertiary center in south India, between June 2018 and February 2019, consisting of pre‐eclamptic women who were recruited as part of an ongoing cohort and had completed at least 3 months of postpartum follow‐up. Demographic, medical, and laboratory details were collected. Primary outcome was a diagnosis of new‐onset PPCH at 3 months. Results PPCH at 3 months was noted in 32 (18.1%) women. During postnatal follow‐up, 2 (1.1%) women experienced hemiplegia from stroke and 19 (10.7%) had elevated serum creatinine levels (>1.1 mg/dL). On multivariate analysis, advancing maternal age (adjusted odds ratio [aOR] 1.10, 95% confidence interval [CI] 1.01–1.21), multiparity (aOR 2.79, 95% CI 1.07–7.24), and eclampsia (aOR 3.07, 95% CI 1.03–9.13) increased the risk of PPCH at 3 months postpartum. Conclusion One in five women present with a diagnosis of new‐onset PPCH within 3 months postpartum in a cohort of predominantly preterm and/or severe pre‐eclampsia. A significant but weak association of PPCH with peripartum clinical characteristics was noted. The role of biochemical, hemodynamic, and echocardiographic biomarkers should be evaluated for prediction of PPCH after pre‐eclampsia in future studies.

show abstract

FIGO (International Federation of Gynecology and Obstetrics) Postpregnancy Initiative: Long‐term Maternal Implications of Pregnancy Complications—Follow‐up Considerations

Cited by 60 publications

References 225 publications

Management of prepregnancy, pregnancy, and postpartum obesity from the FIGO Pregnancy and Non‐Communicable Diseases Committee: A FIGO (International Federation of Gynecology and Obstetrics) guideline

Management of prepregnancy, pregnancy, and postpartum obesity from the FIGO Pregnancy and Non‐Communicable Diseases Committee: A FIGO (International Federation of Gynecology and Obstetrics) guideline

Gestational Diabetes Type 2: Variation in High-Density Lipoproteins Composition and Function

Influence of maternal and perinatal characteristics on risk of postpartum chronic hypertension after pre‐eclampsia

Contact Info

Product

Resources

About